Peer-influenced content. Sources you trust. No registration required. This is HCN.
Medical Professionals Reference (MPR)
The recent phase 1/2 study of Pfizer-BioNTech’s combination vaccine candidate demonstrated robust immune responses to influenza A, influenza B, and SARS-CoV-2 strains. This promising development could significantly impact global immunization practices.
Allergy & Immunology October 30th 2023
ACP Internist
Dive deeper into the complexities of diagnosing and treating pneumonia-associated pleural effusions. What is the most appropriate test for evaluation?
Allergy & Immunology October 25th 2023
Stay informed about the latest advancements in immunization practices. Learn more about the new FDA-approved RSV vaccines and their potential impact on patient care.
Family Medicine/General Practice October 11th 2023
ACIP’s endorsement of Abrysvo offers a new preventive measure against RSV in infants, urging healthcare providers to discuss this option with expectant parents.
Allergy & Immunology October 4th 2023
Cancer Therapy Advisor
Recent findings from the MARS 2 trial challenge traditional treatment protocols for mesothelioma, indicating that chemotherapy alone may offer improved outcomes over combined surgical approaches. Discover why experts are re-evaluating long-standing surgical treatments.
Oncology, Medical September 25th 2023
Pulmonary Fibrosis News
Discover how engineered stem cells could revolutionize the treatment of chronic lung diseases, including pulmonary fibrosis, by offering a more personalized and sustainable approach.
Pulmonology September 13th 2023